Antigua and Barbuda - Re-Export of Vaccines for Human Use
Since 2014, Antigua and Barbuda Re-Export of Vaccines for Human Use grew 51.1% year on year. In 2019, the country was number 16 comparing other countries in Re-Export of Vaccines for Human Use at $20,516. Antigua and Barbuda is overtaken by Oman, which was number 15 with $24,790.64 and is followed by Brunei at $7,131.01. United States topped the ranking with $21,386,560.62 in 2019, -18% compared to 2018. United Arab Emirates, Canada and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. Guyana recorded the best 5 years average growth at +106.5% per year, while Trinidad and Tobago was the worst growing country at -49.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 20,516.00 |
| 2018 | 19,383.40 |
| 2017 | 25,374.90 |
| 2016 | 1,412.00 |
| 2015 | 4,868.00 |
Download all data from 1999 to 2019
How does Antigua and Barbuda rank in Re-Export of Vaccines for Human Use?
| # | 22 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
21,386,560.62 | 2019 | -18.0 % | -6.8 % | View data | |
| 2 |
#2
United Arab Emirates
|
7,990,507.15 | 2019 | +36.5 % | +27.7 % | View data | |
| 15 |
#15
Oman
|
24,790.63 | 2016 | NA | -25.0 % | View data | |
| 16 |
#16
Antigua and Barbuda
|
20,516.00 | 2019 | +5.8 % | +51.1 % | View data | |
| 17 |
#17
Brunei
|
7,131.01 | 2018 | NA | NA | View data | |